Receptor Mediated Targeting of Lectin Conjugated Gliadin Nanoparticles in the Treatment of Helicobacter pylori

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.11, Iss.7, 2003-08, pp. : 415-424

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Helicobacter pylori in gastric carcinogenesis

By Lee Dong Soo Moss Steven F

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 757-769

Informa Healthcare

Access to resources Recommend Favorite

Current options for the treatment of Helicobacter pylori

By Georgopoulos Sotirios D Papastergiou Vasilios Karatapanis Stylianos

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 211-223

Informa Healthcare

Access to resources Recommend Favorite

Helicobacter pylori: 20 years on

By Marshall Barry

Clinical Medicine, Vol. 2, Iss. 2, 2002-03 ,pp. : 147-152

Royal College Of Physicians

Access to resources Recommend Favorite

Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics

By Sugimoto Mitsushige Furuta Takahisa Shirai Naohito Kodaira Chise Nishino Masafumi Yamade Mihoko Ikuma Mutsuhiro Watanabe Hiroshi Ohashi Kyoichi Hishida Akira Ishizaki Takashi

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2701-2717

Informa Healthcare

Access to resources Recommend Favorite

Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori

By Ramteke Suman Jain Narendra

Journal of Drug Targeting, Vol. 16, Iss. 1, 2008-01 ,pp. : 65-72

Informa Healthcare

Access to resources Recommend Favorite